Table 1 Outcomes from index admissions to introduce tension-free vaginal (TVT), trans-obturator (TOT) and suprapubic sling (SS) surgical mesh products in the treatment of stress urinary incontinence.
Unconfounded cohort† | Confounded cohort‡ | |||||
|---|---|---|---|---|---|---|
TVT | TOT | SS | TVT | TOT | SS | |
Patients | 41,880 | 25,509 | 613 | 14,768 | 9195 | 221 |
Elective admissions (%) | 41,831 (99.9) | 25,490 (99.9) | 611 (99.7) | 14,722 (99.7) | 9180 (99.8) | 220 (99.5) |
Number of hospitals | 175 | 170 | 67 | 172 | 158 | 54 |
Age, years: median (lower quartile, upper quartile) | 50 (44, 60) | 51 (44, 61) | 52 (45, 62) | 51 (44, 62) | 51 (45, 63) | 50 (41, 63) |
Endoscopic examination of bladder/urethra (%) | 11,466 (27.4) | 5477 (21.5) | 125 (20.4) | 3781 (25.6) | 1825 (19.8) | 53 (24.0) |
Catheterisations (%) | 928 (2.2) | 444 (1.7) | 11 (1.8) | 759 (5.1) | 324 (3.5) | 27 (12.2) |
Length of stay, days median (lower quartile, upper quartile) | 1 (0, 1) | 1 (0, 1) | 2 (0, 4) | 2 (1, 3) | 2 (1, 3) | 3 (2, 7) |
In-hospital deaths | 0 | 0 | 0 | 0 | 0 | 0 |
Procedures with in-hospital complications (%) | 1232 (2.9) | 356 (1.4) | 30 (4.9) | 880 (6.0) | 342 (3.7) | 23 (10.4) |
Complication attribution: | ||||||
- Procedural (%)† | 656 (53.2) | 90 (25.3) | 19 (63.3) | 453 (51.5) | 161 (47.1) | 17 (73.9) |
- Device (%)† | 83 (6.7) | 28 (7.9) | 4 (13.3) | 62 (7.0) | 21 (6.1) | 0 |
- Complications with urinary symptoms (%)* | 416 (33.8) | 172 (48.3) | 4 (13.3) | 210 (23.3) | 99 (28.9) | 2 (8.7) |
- Other complications (%)* | 140 (11.4) | 76 (21.3) | 6 (20.0) | 204 (23.9) | 76 (22.2) | 6 (26.1) |
